News
+1
Jan 15, 2026
•
2 min read
CamDiab Gets CE Mark for its Fully Closed-Loop Insulin Delivery Algorithm
The latest AID algorithm approval allows insulin automation without carb counting or pre-meal boluses for diabetes management.
News
+2
Jan 14, 2026
•
3 min read
Sequel Med Tech Partners with Diabeloop to Bring FDA Cleared DBLG2 Algorithm to the Twiist Pump
The collaboration moves twiist closer to a fully closed-loop insulin delivery and marks Diabeloop’s first commercial pump integration in the U.S.
News
+2
Jan 13, 2026
•
3 min read
MiniMed Go Smart MDI System Gets FDA Cleared with Instinct CGM Integration
MiniMed Go connects InPen to the Instinct continuous glucose monitor to provide dosing alerts and insights to MDI users with type 1 and 2 diabetes.
News
+2
Jan 8, 2026
•
3 min read
Withings Partners with Abbott Lingo to Bring Glucose Data into to its App
The new collaboration adds glucose insights to the already thorough metabolic tracking in the Withings connected health tech ecosystem.
News
+1
Jan 4, 2026
•
7 min read
Our Top 10 YouTube Videos of 2025
Our most-watched diabetes tech videos of 2025 from CGMs and insulin pumps to tech reviews and what’s coming next.
News
+1
Jan 4, 2026
•
6 min read
Top 10 Podcast Episodes of 2025
Here are the most listened to Diabetech podcast episodes of 2025, featuring expert interviews, diabetes tech and cure resear, and the future of diabetes technology.
CGM
+3
Dec 18, 2025
•
4 min read
FreeStyle Libre App Gets Apple Watch App & AI Food Assistant
The updated Libre app brings Apple Watch support and a new feature called Libre Assist which uses AI meal analysis giving Libre users insights for meals.
Dexcom
+1
Dec 10, 2025
•
4 min read
Dexcom G6 Will Get Discontinued in 2026 - What The Community is Saying
Dexcom is set to end production of the Dexcom G6 on July 1, 2026 and begin shifting users toward its Dexcom G7 platform.
News
+4
Dec 3, 2025
•
3 min read
Twiist Partners with Arecor to Bring Concentrated Insulin to an Insulin Pump
The collaboration could aid insulin delivery for people who require higher doses and extend wear time. Trials are expected to begin in 2026.
News
+2
Dec 2, 2025
•
2 min read
Abbott Recalls Millions of Libre 3 CGMs – Are Yours Affected?
Abbott recalls 3 million Libre 3 CGMs after detecting potential low glucose reading errors, impacting user safety, with 736 reported adverse events and seven deaths.
News
+2
Nov 25, 2025
•
4 min read
Omnipod 5 Algorithm Updates and CGM Integrations Planned For 2026
The algorithm update brings a reduced glucose target, enhanced algorithm performance, wider CGM choice, and a new insights platform called Discover.
News
+1
Nov 24, 2025
•
4 min read
Insulet Announces Discover – A Data Insights Platform Coming in 2026
The upcoming platform will deliver weekly insights to help pump users and HCPs simplify AID data review for Omnipod 5 and Omnipod DASH.
Dexcom
+3
Nov 20, 2025
•
3 min read
The 15-Day Dexcom G7 Arrives in the U.S. on December 1st
Longer wear, improved accuracy and new features arrive with Dexcom’s latest G7 CGM update.
Dexcom
+3
Nov 19, 2025
•
3 min read
Dexcom Smart Basal Gets FDA Clearance as First CGM Basal Insulin Optimizer
The company’s latest feature uses continuous data to guide daily basal dose adjustments for people with type 2 diabetes.
News
+3
Nov 11, 2025
•
3 min read
Tandem Mobi Android App Receives FDA Clearance
Tandem Mobi users will be able to control their pump with Android phones later this year.
CGM
+2
Nov 6, 2025
•
3 min read
Eversense 365 CGM is Submitted for CE Mark Approval
The regulatory milestone positions Eversense 365 for a 2026 European launch and marks a major step forward in long-term glucose monitoring technology.
News
+1
Nov 4, 2025
•
3 min read
ŌURA and Tidepool Join Forces to Advance Diabetes Research
The collaboration will link wearable, sleep, and menstrual cycle data with glucose trends to close long-standing gaps in women’s health and diabetes research.
News
+1
Oct 29, 2025
•
2 min read
California Caps Monthly Insulin at $35 and Launches $11 CalRx Insulin Pens to Tackle Drug Costs
New laws and state-run manufacturing aim to make insulin more affordable to all Californians starting in 2026, setting a national example for diabetes care reform.
